Novel solution developed by Schreiner MediPharm and Edelmann
In a joint venture with the packaging manufacturer, Edelmann, Schreiner MediPharm has developed an innovative solution that makes important product information accessible without opening the pharmaceutical pack. The packaging solution is based on the requirements of the EU Falsified Medicines Directive 2011/62/EU.
Among other things, the EU directive requires a security seal for the outer packaging of medicines to prevent manipulation. Pharmacists can then only read the package insert after destroying the seal, which is meant to form a barrier and to serve as a first-opening indicator.
To avoid this, Schreiner MediPharm and Edelmann have developed a novel solution combining a folding box with a booklet-label applied to the outside.
Applied to the outer packaging, the multi-page booklet-label from Schreiner MediPharm makes even multilingual product information easily accessible and readily visible without damaging the original pack. It reliably adheres to the medicine pack and is easy to open and close again.
The booklet-label is additionally equipped with a colour-shifting ink for integrated protection against counterfeiting.
‘The solution that has been jointly developed with Edelmann maintains the integrity of the pack, while allowing easy access to the package insert,’ says Robert Unglert, Senior Sales Director at Schreiner MediPharm. The patient benefits from the booklet applied to the pack as well, because it is easy to open and close again. As the booklet is firmly attached to the pack, it is also less likely to be misplaced.